One of the listed companies, Navana Pharmaceuticals Limited, discloses its financial reports for the second quarter, (October-December 22). This source is known from DSE.
The company’s earnings per share (EPS) of Tk 0.77 paisa in Q2 of the current financial year. EPS was Tk 0.78 paisa during the same period last year. As of December 31, 2022, the net asset value (NAVPS) was Tk 39.56 paisa.
/NR
Share this
